Abstract
The serotonin agonist quipazine maleate (1–10 mg/kg, IM) and the serotonin precursor l-5-hydroxytryptophan (5HTP, 3–30 mg/kg, IM) produced dose-dependent decreases in responding (lever-pressing) of squirrel monkeys maintained under a fixed-ratio 30 schedule of food presentation. The classical serotonin antagonist methysergide antagonized the behavioral effects of both quipazine and 5HTP. The behavioral effects of quipazine but not 5HTP were antagonized by the selective serotonin-2 receptor antagonist ketanserin. These results suggest that decreases in food-maintained responding may be produced independently by stimulation of either serotonin-1 or serotonin-2 receptor subtypes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barrett RJ, Blackshear MA, Sanders-Buch E (1982) Discriminative stimulus properties of L-5-hydroxytryptophan. Psychopharmacology 76:29–35
Brady LS, Barrett JE (1985a) Effects of serotonin receptor agonists and antagonists on schedule-controlled behavior of squirrel monkeys. J Pharmacol Exp Ther 235:436–441
Brady LS, Barrett JE (1985b) Effects of serotonin receptor antagonists on punished responding maintained by stimulus-shock termination or food presentation in squirrel monkeys. J Pharmacol Exp Ther 234:106–112
Carter RB, Dykstra LA, Leander JD, Appel JB (1978) Role of peripheral mechanisms in the behavioral effects of 5-hydroxytryptophan. Pharmacol Biochem Behav 9:249–253
Colpaert FC (1982) A drug discrimination analysis of lysergic acid diethylamide (LSD): in vitro agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD-antagonist. J Pharmacol Exp Ther 221:206–214
Cunningham KA, Callahan PM, Appel JB (1985) Differentiation between the stimulus effects of l-5-hydroxytryptophan and LSD. Eur J Pharmacol 108:179–186
Friedman RL, Barrett RJ, Sanders-Bush E (1983) Additional evidence that l-5-hydroxytryptophan discrimination models a unique serotonin receptor. Psychopharmacology 80:209–213
Friedman RL, Barrett RJ, Sanders-Bush E (1984) Discriminative stimulus properties of quipazine: mediation by serotonin-2 binding sites. J Pharmacol Exp Ther 228:628–635
Fuller RW (1980) Pharmacology of central serotonin neurons. Annu Rev Pharmacol Toxicol 20:111–127
Goldstein A (1964) Biostatistics: An introductory text. MacMillan, New York, pp 59–61
Hake DF, Azrin NH (1963) An apparatus for delivering pain shock to monkeys. J Exp Anal Behav 6:297–298
Jaeger CB, Teitelman G, Joh TH, Albert VR, Park DH, Reis DJ (1983) Some neurons of the rat central nervous system contain aromatic l-amino-acid decarboxylase but not monoamines. Science 219:1233
Leander JD (1981) Antagonism by methysergide of the effects of l-5-hydroxytryptophan and quipazine on schedule-controlled responding. Neuropharmacology 20:1141–1143
Lysen JE, Tollenaere JP (1982) Biochemical models for serotonin receptors. In: McDermed J (ed) Annual reports in medicinal chemistry-17. Academic Press, New York, pp 1–10
Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenbeck J, Janssen PAJ (1981) Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. Life Sci 28:1015–1022
Lucki J, Nobler MS, Frazer A (1984) Differential actions of serotonin antagonists on two behavioral models for serotonin receptor activation in the rat. J Pharmacol Exp Ther 228:133–139
McKearney JW (1985) Differential block of behavioral effects of serotonin (5-HT) agonists by selective and non-selective antagonists. Pharmacologist 27:194
Möhler DJ, Stoudt KW, Rech RH (1985) The 5HT2 antagonist pirenperone reverses disruption of FR-40 by hallucinogenic drugs. Pharmacol Biochem Behav 22:677–682
Ng LKY, Chase TN, Colburg RW, Kopin JJ (1972) Release of 3H-dopamine by l-5-hydroxytryptophan. Brain Res 45:499–505
Ortmann R (1984) The 5-HT syndrome in rats as tool for the screening of psychoactive drug 4:593–606
Peroutka SJ, Lebovitz RM, Snyder SH (1981) Two distinct central serotonin receptors with different physiological functions. Science 212:827–829
Roberts MHT, Straughn DW (1967) Excitation and depression of cortical neurones by 5-hydroxytryptamine. J Physiol 103:269–294
Seiden LS, Dykstra LA (1977) Psychopharmacology: A biochemical and behavioral approach. Van Nostrand Reinhold, New York
White FJ, Kuhn DM, Appel JB (1977) Discriminative stimulus properties of quipazine. Neuropharmacology 16:827–832
White FJ, Appel JB, Kuhn DM (1979) Discriminative stimulus properties of quipazine: direct serotonergic mediation. Neuropharmacology 18:143–151
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Witkin, J.M., Brady, L.S. & Barrett, J.E. Antagonism by ketanserin of the behavioral effects of quipazine but not l-5-hydroxytryptophan in squirrel monkeys. Psychopharmacology 94, 302–305 (1988). https://doi.org/10.1007/BF00174679
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00174679